Position in ERAS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,682
+$5,146 QoQ
Shares Held
413
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rialto Wealth Management, LLC holds $832,682 across 47 Biotechnology names. ERAS ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MESO |
Mesoblast Ltd
|
46,500 | $715,170 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
86 | $38,402 | |
| 3 | ABSI |
Absci Corp
|
3,600 | $10,800 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
1,450 | $9,265 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
162 | $8,540 | |
| 6 | GOSS |
Gossamer Bio, Inc.
|
20,552 | $6,761 | |
| 7 | ERAS |
Erasca, Inc.
This page
|
413 | $6,682 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7 | $5,408 |
All Filings in ERAS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,682 | 413 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,536 | 413 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $900 | 413 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $524 | 413 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||